Kelvin Chiu and Isabelle Dutry of Sanwa BioTech in Hong Kong highlight the critical importance of personalised fast-track diagnostics in countering the COVID-19 pandemic, the role that Asian firms have to play in remedying the global shortage of medical supplies, and what the future holds for Sanwa.
Looking at the longer term, I believe this COVID-19 crisis will have a positive impact on the diagnostics industry by changing the approach countries take towards the incorporation of preventative healthcare into their healthcare systems
